title: [The treatment of atypical manias with finlepsin-retard].
abstract: The article presents results of clinical trial of finlepsine-retard. Objectivized parameters characterizing the time course of psychopathologic symptoms were studied in certain concentrations of finlepsine and beta-endrofin in blood serum. Atypical maniac states do not easily respond to therapies but finlepsine-retard gives the modern psychopharmacotherapy a new horizon.
authors.forename: H K
authors.initials: HK
authors.lastname: Dziub
authors.forename: A P
authors.initials: AP
authors.lastname: Chuprykov
authors.forename: A S
authors.initials: AS
authors.lastname: Harnyts'ka
authors.forename: V O
authors.initials: VO
authors.lastname: Protsyk
authors.forename: V M
authors.initials: VM
authors.lastname: Os'kina
authors.forename: O I
authors.initials: OI
authors.lastname: Benes'ko
mesh_terms: D000328:Adult; D018692:Antimanic Agents / Q000097:blood / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D002220:Carbamazepine / Q000097:blood / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D018692:Antimanic Agents; D003692:Delayed-Action Preparations; D002220:Carbamazepine